PRISM Mid-Day Movers: Strategic Efforts Drive Downside in Healthcare, Purchasing Orders Up for 5G Technology in Space Index

Biomerica Plunges 25% on Reverse Stock Split Announcement
Biomerica, Inc. (BMRA) tumbled over 24% midday, weighing on the PRISM Emerging Healthcare Index, after the company announced a 1-for-8 reverse stock split aimed at regaining Nasdaq compliance. The split will go into effect on April 21, 2025, reducing the number of shares outstanding from approximately 20.4 million to around 2.5 million, while leaving the number of authorized shares unchanged. This announcement follows yesterday's 3Q financial release in which the company disclosed a $3M cash position and an over 55% reduction of its cash burn, achieving annual cost savings earlier than anticipated.

The stock split decision received shareholder approval during Biomerica's 2024 Annual Meeting and is a strategic effort to lift the company's share price above the Nasdaq minimum bid requirement. All fractional shares will be rounded up, and the stock will trade under the same ticker "BMRA" with a new CUSIP number. While such structural changes are often viewed as cautionary, the company maintains a pipeline focused on diagnostics and treatments for gastrointestinal and inflammatory conditions, including its inFoods(R) IBS platform.

AmpliTech Jumps 22% on $11M 5G ORAN Orders from Tier 1 Carrier
AmpliTech Group, Inc. (AMPG) surged 22% midday, climbing within the PRISM Emerging Space Index after announcing record-breaking purchase orders totaling approximately $11 million tied to a multi-year agreement with a leading Tier 1 North American mobile network operator. These orders are part of a larger commercial engagement that includes more than $100 million in signed Letters of Intent (LOIs) with two top-tier 5G ORAN telecom customers.

CEO Fawad Maqbool called the new orders "a milestone achievement" and emphasized the company's rapid emergence as a competitive force in the global 5G Open Radio Access Network (ORAN) space. AmpliTech has already secured $12 million in firm POs for fulfillment in fiscal year 2025, reflecting growing demand for its proprietary ORAN 5G radio products.

"This new engagement highlights the demand for our differentiated ORAN 5G technology," Maqbool noted, adding that the back-to-back LOIs underscore AmpliTech's commercial readiness and scaling capabilities.

Other PRISM Mid-Day Movers:

• Cara Therapeutics (CARA) up 192.31%
• Canopy Growth Corp. (CGC) up 19.31%
• Palatin Technologies Inc. (PTN) up 21.77%

The post PRISM Mid-Day Movers: Strategic Efforts Drive Downside in Healthcare, Purchasing Orders Up for 5G Technology in Space Index appeared first on PRISM MarketView.

COMTEX_464620709/2927/2025-04-16T15:31:21